KR970700772A - T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof) - Google Patents

T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof)

Info

Publication number
KR970700772A
KR970700772A KR1019960703802A KR19960703802A KR970700772A KR 970700772 A KR970700772 A KR 970700772A KR 1019960703802 A KR1019960703802 A KR 1019960703802A KR 19960703802 A KR19960703802 A KR 19960703802A KR 970700772 A KR970700772 A KR 970700772A
Authority
KR
South Korea
Prior art keywords
antigen receptor
cell
cell antigen
preparation
manufacturing
Prior art date
Application number
KR1019960703802A
Other languages
English (en)
Other versions
KR100213396B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR970700772A publication Critical patent/KR970700772A/ko
Application granted granted Critical
Publication of KR100213396B1 publication Critical patent/KR100213396B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
KR1019960703802A 1994-01-13 1995-01-12 T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법 KR100213396B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8/181,492 1994-01-13
US08/181,492 US5552300A (en) 1994-01-13 1994-01-13 T cell antigen receptor V region proteins and methods of preparation thereof
PCT/US1995/000408 WO1995019435A2 (en) 1994-01-13 1995-01-12 T cell antigen receptor v region proteins and methods of preparation thereof

Publications (2)

Publication Number Publication Date
KR970700772A true KR970700772A (ko) 1997-02-12
KR100213396B1 KR100213396B1 (ko) 1999-08-02

Family

ID=22664497

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960703802A KR100213396B1 (ko) 1994-01-13 1995-01-12 T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법

Country Status (21)

Country Link
US (1) US5552300A (ko)
EP (1) EP0738322A1 (ko)
JP (1) JPH10501961A (ko)
KR (1) KR100213396B1 (ko)
AU (1) AU700661B2 (ko)
BR (1) BR9506612A (ko)
CA (1) CA2181171A1 (ko)
CZ (1) CZ9602009A3 (ko)
EE (1) EE03287B1 (ko)
FI (1) FI962844A (ko)
HU (1) HUT75551A (ko)
IL (1) IL112316A0 (ko)
LV (1) LV11630B (ko)
MX (1) MX9602750A (ko)
NO (1) NO962921L (ko)
NZ (2) NZ279605A (ko)
PL (1) PL181072B1 (ko)
SG (1) SG52342A1 (ko)
SK (1) SK90696A3 (ko)
WO (1) WO1995019435A2 (ko)
ZA (1) ZA95261B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US7749498B2 (en) * 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) * 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) * 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US20040229282A1 (en) * 1997-03-10 2004-11-18 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
AU4188100A (en) 1999-04-08 2000-11-14 Gregory M. Glenn Dry formulation for transcutaneous immunization
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20030190705A1 (en) * 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
ES2537951T3 (es) 2002-08-08 2015-06-16 Baylor College Of Medicine Aislamiento e identificación de células T
ES2527102T3 (es) * 2003-06-19 2015-01-20 Genentech, Inc. Composiciones y métodos para el tratamiento de trastornos relacionados con la coagulación
US20070292445A1 (en) * 2004-07-06 2007-12-20 Transpharma Medical Ltd. Delivery system for transdermal immunization
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
US20070009542A1 (en) 2005-07-05 2007-01-11 Galit Levin Method and device for transdermal immunization
EP1928537B1 (en) 2005-09-02 2015-01-21 Intercell USA, Inc. Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs
NZ572644A (en) * 2006-05-05 2012-06-29 Opexa Therapeutics T-cell vaccine
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
US9181527B2 (en) 2009-10-29 2015-11-10 The Trustees Of Dartmouth College T cell receptor-deficient T cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2013033626A2 (en) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Nkp30 receptor targeted therapeutics
ES2719495T3 (es) 2012-05-07 2019-07-10 Dartmouth College Anticuerpo dirigido contra b7-h6, proteínas de fusión, y métodos de uso de los mismos
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
WO1985003947A1 (en) * 1984-03-01 1985-09-12 The Board Of Trustees Of The Leland Stanford Jr. U T-cell receptor-specific for antigen polypeptides and related polynucleotides
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5185250A (en) * 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
US5260223A (en) * 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
US5024940A (en) * 1987-02-19 1991-06-18 T Cell Sciences, Inc. Nucleic acids encoding the delta chain of the T cell antigen receptor
EP0296786B1 (en) * 1987-06-23 1996-10-30 The Board Of Trustees Of The Leland Stanford Junior University T-cell receptor gene located within alpha locus and dna constructions
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
JP3472297B2 (ja) * 1989-03-21 2003-12-02 ザ イミューン レスポンス コーポレイション 特定のｔ細胞集団の病原性応答により生じる疾患に対するワクチン接種および方法
WO1990014068A2 (en) * 1989-05-02 1990-11-29 Irun Robert Cohen Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
DK0527199T4 (da) * 1990-05-01 2000-12-04 Univ Leland Stanford Junior Præparater til anvendelse ved en fremgangsmåde tilbehandling af et menneske, der lider afdissemineret sclerose
ATE148499T1 (de) * 1990-08-09 1997-02-15 Nat Jewish Ct Immun & Respirat Herstellung monoklonaler antikörper gegen menschliches vbeta t-zellrezeptorelement unter verwendung rekombinanter dna-vektoren
JPH06502997A (ja) * 1991-02-12 1994-04-07 ルセル　ユクラフ ヒトＴリンパ球レセプターのβ鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用
JPH07502977A (ja) * 1991-05-31 1995-03-30 ゾーマ・コーポレーション 免疫関連疾患用治療薬としてのｔ細胞レセプターペプチド
JPH06511241A (ja) * 1991-09-23 1994-12-15 ジェネンテク，インコーポレイテッド 自己免疫疾患の診断および治療
US5333487A (en) * 1991-11-15 1994-08-02 Hughes Aircraft Company Spark-excited fluorescence sensor
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor

Also Published As

Publication number Publication date
KR100213396B1 (ko) 1999-08-02
ZA95261B (en) 1995-11-14
HU9601908D0 (en) 1996-09-30
LV11630B (en) 1997-08-20
SK90696A3 (en) 1997-07-09
JPH10501961A (ja) 1998-02-24
EE03287B1 (et) 2000-08-15
NO962921L (no) 1996-09-02
MX9602750A (es) 1997-05-31
AU1678495A (en) 1995-08-01
US5552300A (en) 1996-09-03
EP0738322A1 (en) 1996-10-23
HUT75551A (en) 1997-05-28
PL181072B1 (pl) 2001-05-31
WO1995019435A2 (en) 1995-07-20
WO1995019435A3 (en) 1995-08-24
PL319374A1 (en) 1997-08-04
SG52342A1 (en) 1999-06-22
IL112316A0 (en) 1995-03-30
CZ9602009A3 (en) 1997-12-17
CA2181171A1 (en) 1995-07-20
BR9506612A (pt) 1997-09-16
NO962921D0 (no) 1996-07-11
AU700661B2 (en) 1999-01-14
NZ332715A (en) 2000-06-23
FI962844A (fi) 1996-08-29
NZ279605A (en) 1999-01-28
LV11630A (lv) 1996-12-20
FI962844A0 (fi) 1996-07-12

Similar Documents

Publication Publication Date Title
KR970700772A (ko) T 세포 항원 수용체의 v 영역 단백질 및 그것의 제조 방법(t cell antigen receptor v region proteins and methods of preparation thereof)
NO992779D0 (no) OB-fusjonsproteinpreparater og fremgangsmÕte for fremstilling av slike
CY2010017I1 (el) Νεα πρωτεϊνη και μεθοδος παρασκευης αυτης
EE03424B1 (et) Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
HUP0002474A3 (en) Improved anti-ige antibodies and method of improving polypeptides
NZ235315A (en) Chimaeric hepadnavirus core antigen proteins and their construction
PT90312A (pt) Processo para a preparacao de novos anticorpos recombinantes e quimericos dirigidos contra um antigenio de adenocarcinoma humano
DE240975T1 (de) Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.
PT87688A (pt) Hybrid protein c and method for its preparation
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
DK257389A (da) Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf
DE68917273T2 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
DK610587D0 (da) Analysemetode og -saet for antistof til hepatitis b-kerneantigen
SE9602677D0 (sv) Methods for determining brain antigens
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
AU596692B2 (en) DNA coding for antigen protein of rinderpest virus
ZA907279B (en) Antibodies and proteins
DK362088D0 (da) Fusionsproteiner og fusionsproteinpartikler
AU630070B2 (en) Preparation of fused proteins, antibodies and processes therefore
AU1907499A (en) Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of (orientia tsutsugamushi) and its use in antibody based detectionassays and vaccines
AU2003200506A1 (en) Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
DK2990A (da) Valleproteinpraeparat, fremgangsmaade til fremstilling og anvendelse deraf
NO173340C (no) Humant protein C antistoff

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee